KR | EN

News

Press Release

MOU with Probio (China) for mRNA Development and Production

January 15, 2025 4

SML Biopharm signed an MOU with China's Probio for comprehensive cooperation in mRNA development, production, and clinical research.

Back to List

Related News

2025.09.15

MOU Signed with Cha Vaccine Institute for mRNA Vaccine Co-development
2025.05.10

MOU Signed with Affilogic (France) for Targeted Drug Development
2024.12.05

MOU with CATUG (Switzerland) for mRNA Technology Development